FDA Inspection 1332592 — ImpactLife
The FDA completed an inspection of ImpactLife on Aug 14, 2026 in Saint Peters, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Saint Peters, MO (United States)